Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Poland
Clinical trial register · Poland

Clinical Trials in Poland

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2721 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2721
Studies in scope
all four open statuses
1385
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Gdansk 12 Krakow 10 Poznan 9 Warsaw 8 Bydgoszcz 7

Trials in this register

22 of 2721 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Regeneron Pharmaceuticals
Phase 3
270
Skorzewo, Katowice
2026-05-21
Recruiting
Regeneron Pharmaceuticals
Phase 2
99
Poznan, Bialystok, Katowice, Lodz
2026-05-06
Recruiting
Regeneron Pharmaceuticals
Phase 2
120
Przemyśl
2026-04-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
2,000
Krakow, Lodz, Poznan
2025-06-25
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Bydgoszcz, Tarnowskie Góry, Olsztyn
2024-10-30
Recruiting
Regeneron Pharmaceuticals
Phase 2
116
Torun, Wałbrzych, Krakow, Gdansk, Lodz, Kielce
2024-09-16
Recruiting
First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)
NCT06351592Amyotrophic Lateral Sclerosis (ALS), Mutation in the Superoxide Dismutase-1 (SOD1) Gene
Regeneron Pharmaceuticals
Phase 1/2
54
Krakow, Zabrze, Warsaw
2024-08-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Bydgoszcz, Wałbrzych, Wroclaw, Lublin, Krakow, Gdansk, Poznan, Skorzewo
2023-12-28
Recruiting
Regeneron Pharmaceuticals
Phase 3
904
Krakow, Wroclaw, Poznan, Skorzewo, Bydgoszcz, Gdansk, Lublin, Warsaw
2023-12-13
Active, closed
Regeneron Pharmaceuticals
Phase 3
733
Krakow, Skorzewo, Bydgoszcz, Gdansk, Katowice, Lodz, Lublin, Warsaw
2023-11-14
Recruiting
Regeneron Pharmaceuticals
Phase 3
410
Gdansk, Bydgoszcz, Katowice, Lublin, Lodz
2023-09-18
Active, closed
Regeneron Pharmaceuticals
Phase 3
63
Rzeszów
2022-11-21
Active, closed
Regeneron Pharmaceuticals
Phase 3
288
Poznan, Krakow, Warsaw, Gdansk
2021-12-14
Active, closed
Regeneron Pharmaceuticals
Phase 1/2
548
Poznan, Szczecin
2020-12-21
Active, closed
Regeneron Pharmaceuticals
Phase 2
515
Warsaw, Gdansk, Gdynia, Lodz, Wroclaw
2019-11-13
Active, closed
Regeneron Pharmaceuticals
Phase 3
415
Gliwice, Krakow, Poznan, Warsaw
2019-06-04
Rows per page Showing 1–22 of 22
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-poland

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,721 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 22 of those studies that match the filters currently applied.

How many clinical trials are recruiting in Poland?

13 of the 22 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 9 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 22 studies
PhaseStudiesRecruitingShare
Phase 315968.2%
Phase 24318.2%
Phase 1/2219.1%
Phase 4104.5%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
Regeneron Pharmaceuticals2213

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Paroxysmal Nocturnal Hemoglobinuria (2) Follicular Lymphoma (FL) (2) Melanoma (2) Amyotrophic Lateral Sclerosis (ALS) (1) Mutation in the Superoxide Dismutase-1 (SOD1) Gene (1) Pulmonary Arterial Hypertension (PAH) (1) Generalized Myasthenia Gravis (1) Relapsed/Refractory Follicular Lymphoma (1) Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL) (1) Diffuse Large B-cell Lymphoma (DLBCL) (1) Monoclonal Gammopathy of Undetermined Significance (MGUS) (1) Smoldering Multiple Myeloma (SMM) (1) Relapsed Refractory Multiple Myeloma (RRMM) (1) Asthma (1) B-cell Non-Hodgkin Lymphoma (B-NHL) (1)
→

Browse trials by site location

Gdansk (12) Krakow (10) Poznan (9) Warsaw (8) Bydgoszcz (7) Lodz (7) Katowice (5) Wroclaw (5) Skorzewo (5) Lublin (5) Wałbrzych (3) Bialystok (2) Siedlce (2) Słupsk (2) Zabrze (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.